COVID-19 prevention drug coming for immunocompromised New Brunswickers - Yahoo News Canada | Canada News Media
Connect with us

Health

COVID-19 prevention drug coming for immunocompromised New Brunswickers – Yahoo News Canada

Published

 on


The two-shot antibody treatment Evusheld provides protection from COVID-19 for about six months. (Associated Press/Ted Warren – image credit)

A drug that could prevent immunocompromised people from developing COVID-19 will soon be available in New Brunswick.

Evusheld was approved last month by Health Canada for people aged 12 or older who are immunocompromised and unlikely to mount an adequate immune response to COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.

The antibody treatment, developed by AstraZeneca, is administered through two injections before people become infected or have had a known recent exposure to the virus.

“The introduction of this treatment is good news for some specific situations,” Department of Health spokesperson Bruce Macfarlane said in an emailed statement.

“This medication may be part of a treatment plan prescribed by physicians after a clinical assessment to a limited number of individuals.”

Unlike Paxlovid, the other COVID-19 medication currently available in New Brunswick, Evusheld is not authorized to treat COVID-19.

Evusheld is not a substitute for COVID-19 vaccination for those who are eligible either.

But for people with weakened immune systems, such as cancer, transplant or dialysis patients, those with autoimmune conditions or taking immunosuppressive medications, vaccines alone may not offer sufficient protection against COVID-19, the president of AstraZeneca Canada has said.

“The key to ending the COVID-19 pandemic is protecting as many people as possible against infection, including those who may need an additional layer of protection to prevent COVID-19 than vaccines alone can provide,” said Kiersten Combs. The approval of Evusheld, she said, is “an important step along this journey.”

Jonathan Nackstrand/AFP/Getty Images

New Brunswick recorded 15 more COVID-19 deaths in its weekly report Tuesday.

Hospitalizations because of the virus dropped by six, to 81, including 10 people in intensive care, according to the province. The regional health authorities, meanwhile, report there are a total of 123 people with COVID-19 being treated in hospital, 13 of whom require intensive care.

The number of new cases of COVID-19 dropped to 2,534, but that’s based in part on PCR (polymerase chain reaction) results, and about 2,000 fewer tests were performed April 24-30.

Limited supply

Clinical trials found Evusheld cut the risk of developing symptomatic COVID-19 by 77 per cent and the protection lasted for at least six months.

“We are expecting that the supply of this medication will be very limited in our province over the next few months while the federal government works to secure larger quantities,” Macfarlane said.

In February, AstraZeneca announced it had struck a deal with the federal government to supply 100,000 doses of Evusheld to be delivered in 2022, pending its approval in Canada.

While vaccines rely on a person’s natural immune system to develop targeted antibodies and infection-fighting cells, Evusheld contains the lab-made antibodies tixagevimab and cilgavimab, which are designed to linger in the body for months to contain the virus in case of an infection.

Common side effects, expected in one in 10 people, may include a rash or hives, or injection site reaction, such as pain, redness, itching and swelling.

Uncommon side effects, expected in one in 100 people, may include headache, chills, and redness, discomfort or soreness near the injection site.

There isn’t enough data yet to be sure Evusheld is safe for use by those pregnant or breastfeeding. Health Canada recommends those individuals discuss the potential benefits and risks with a health-care provider.

“The best defence against Omicron is vaccination and we urge everyone to ensure they get their booster dose as soon as possible,” said Macfarlane.

A total of 52 per cent of eligible New Brunswickers are now boosted after 885 more people received their COVID-19 booster shot, Public Health reported Tuesday, up from 51.9 per cent a week ago.

A total of 87.9 per cent have received two doses, up from 87.8 per cent (233 more people), and 93.1 per cent have received their first dose, unchanged again (146 more people).

Evusheld is expected to “retain neutralizing activity against Omicron subvariant BA.2, which is now the dominant variant in many communities in Canada,” Health Canada has said.

As one of the conditions of authorization, AstraZeneca must continue to provide Health Canada with information on the safety and efficacy of Evusheld, including protection against current and emerging variants of concern, as soon as it’s available.

Adblock test (Why?)



Source link

Continue Reading

Health

Whooping cough is at a decade-high level in US

Published

 on

 

MILWAUKEE (AP) — Whooping cough is at its highest level in a decade for this time of year, U.S. health officials reported Thursday.

There have been 18,506 cases of whooping cough reported so far, the Centers for Disease Control and Prevention said. That’s the most at this point in the year since 2014, when cases topped 21,800.

The increase is not unexpected — whooping cough peaks every three to five years, health experts said. And the numbers indicate a return to levels before the coronavirus pandemic, when whooping cough and other contagious illnesses plummeted.

Still, the tally has some state health officials concerned, including those in Wisconsin, where there have been about 1,000 cases so far this year, compared to a total of 51 last year.

Nationwide, CDC has reported that kindergarten vaccination rates dipped last year and vaccine exemptions are at an all-time high. Thursday, it released state figures, showing that about 86% of kindergartners in Wisconsin got the whooping cough vaccine, compared to more than 92% nationally.

Whooping cough, also called pertussis, usually starts out like a cold, with a runny nose and other common symptoms, before turning into a prolonged cough. It is treated with antibiotics. Whooping cough used to be very common until a vaccine was introduced in the 1950s, which is now part of routine childhood vaccinations. It is in a shot along with tetanus and diphtheria vaccines. The combo shot is recommended for adults every 10 years.

“They used to call it the 100-day cough because it literally lasts for 100 days,” said Joyce Knestrick, a family nurse practitioner in Wheeling, West Virginia.

Whooping cough is usually seen mostly in infants and young children, who can develop serious complications. That’s why the vaccine is recommended during pregnancy, to pass along protection to the newborn, and for those who spend a lot of time with infants.

But public health workers say outbreaks this year are hitting older kids and teens. In Pennsylvania, most outbreaks have been in middle school, high school and college settings, an official said. Nearly all the cases in Douglas County, Nebraska, are schoolkids and teens, said Justin Frederick, deputy director of the health department.

That includes his own teenage daughter.

“It’s a horrible disease. She still wakes up — after being treated with her antibiotics — in a panic because she’s coughing so much she can’t breathe,” he said.

It’s important to get tested and treated with antibiotics early, said Dr. Kris Bryant, who specializes in pediatric infectious diseases at Norton Children’s in Louisville, Kentucky. People exposed to the bacteria can also take antibiotics to stop the spread.

“Pertussis is worth preventing,” Bryant said. “The good news is that we have safe and effective vaccines.”

___

AP data journalist Kasturi Pananjady contributed to this report.

___

The Associated Press Health and Science Department receives support from the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Scientists show how sperm and egg come together like a key in a lock

Published

 on

 

How a sperm and egg fuse together has long been a mystery.

New research by scientists in Austria provides tantalizing clues, showing fertilization works like a lock and key across the animal kingdom, from fish to people.

“We discovered this mechanism that’s really fundamental across all vertebrates as far as we can tell,” said co-author Andrea Pauli at the Research Institute of Molecular Pathology in Vienna.

The team found that three proteins on the sperm join to form a sort of key that unlocks the egg, allowing the sperm to attach. Their findings, drawn from studies in zebrafish, mice, and human cells, show how this process has persisted over millions of years of evolution. Results were published Thursday in the journal Cell.

Scientists had previously known about two proteins, one on the surface of the sperm and another on the egg’s membrane. Working with international collaborators, Pauli’s lab used Google DeepMind’s artificial intelligence tool AlphaFold — whose developers were awarded a Nobel Prize earlier this month — to help them identify a new protein that allows the first molecular connection between sperm and egg. They also demonstrated how it functions in living things.

It wasn’t previously known how the proteins “worked together as a team in order to allow sperm and egg to recognize each other,” Pauli said.

Scientists still don’t know how the sperm actually gets inside the egg after it attaches and hope to delve into that next.

Eventually, Pauli said, such work could help other scientists understand infertility better or develop new birth control methods.

The work provides targets for the development of male contraceptives in particular, said David Greenstein, a genetics and cell biology expert at the University of Minnesota who was not involved in the study.

The latest study “also underscores the importance of this year’s Nobel Prize in chemistry,” he said in an email.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Turn Your Wife Into Your Personal Sex Kitten

Published

 on

Product Name: Turn Your Wife Into Your Personal Sex Kitten

All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Turn Your Wife Into Your Personal Sex Kitten is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.

(more…)

Continue Reading

Trending

Exit mobile version